Average Co-Inventor Count = 4.02
ph-index = 17
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Bayer Healthcare LLC (17 from 780 patents)
2. Bayer Intellectual Property Gmbh (12 from 721 patents)
3. Bayer Pharmaceuticals Corporation (8 from 70 patents)
4. Other (5 from 832,843 patents)
5. Bayer Corporation (3 from 1,008 patents)
6. Bayer Pharma Aktiengesellschaft (3 from 378 patents)
7. Bayer Aktiengesellschaft (1 from 12,160 patents)
8. Bayer Pharma Aktiengesselschaft (1 from 1 patent)
49 patents:
1. 11901928 - Systems and methods for a cellular phone enclosure
2. 11146301 - Systems and methods for a cellular phone enclosure
3. 10653684 - Aryl ureas with angiogenisis inhibiting activity
4. 10130633 - Compounds
5. RE46856 - Substituted 2,3-dihydroimidazo[1,2-c]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
6. 9902727 - Aminoalcohol substituted 2,3-dihydroimidazo[1,2-C]quinazoline derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
7. 9730943 - Alkoxy-substituted 2,3-dihydroimidazo[1,2-C]quinazolines
8. 9675616 - Arylaminoalcohol-substituted 2,3-dihydroimidazo[1,2-C]quinolines
9. 9604989 - Imidazopyridazines as Akt kinase inhibitors
10. 9370517 - Substituted pyrazolopyrimidines as Akt kinase inhibitors
11. 9260435 - Substituted imidazopyrazines as Akt kinase inhibitors
12. 9206185 - Imidazopyridazines as Akt kinase inhibitors
13. 9199999 - Substituted imidazopyrazines
14. 9181188 - Aryl ureas as kinase inhibitors
15. 8975265 - Substituted imidazo[1,2-a]pyrimidines and —pyridines